| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.007 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.007 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.007 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.089 | 0.008 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.092 | 0.01 |